858674-11-0 Usage
Uses
Used in Pharmaceutical Industry:
[1,1-Biphenyl]-4-carboxaldehyde,2-hydroxy-(9CI) is used as a building block for the synthesis of various pharmaceuticals due to its unique chemical structure and properties. Its ability to be incorporated into the development of new drugs makes it a valuable compound in the pharmaceutical industry.
Used in Agrochemical Industry:
In the agrochemical industry, [1,1-Biphenyl]-4-carboxaldehyde,2-hydroxy-(9CI) is utilized in the synthesis of organic compounds that can be used as active ingredients in pesticides, herbicides, and other agrochemical products. Its versatility in chemical reactions allows for the creation of a wide range of compounds with potential applications in agriculture.
Used in Chemical Research:
[1,1-Biphenyl]-4-carboxaldehyde,2-hydroxy-(9CI) is also used in chemical research as a potential drug target. Its unique properties and structure make it an interesting candidate for further study, with the potential to lead to the development of new drugs and therapies.
Further research is needed to fully understand the biological and chemical properties of [1,1-Biphenyl]-4-carboxaldehyde,2-hydroxy-(9CI) and to explore its potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 858674-11-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,8,6,7 and 4 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 858674-11:
(8*8)+(7*5)+(6*8)+(5*6)+(4*7)+(3*4)+(2*1)+(1*1)=220
220 % 10 = 0
So 858674-11-0 is a valid CAS Registry Number.
858674-11-0Relevant articles and documents
BENZIMIDAZOLE DERIVATIVES AND MEDICAL USES THEREOF
-
Page/Page column 34, (2008/06/13)
The present invention providesbenzimidazole derivatives represented by the following formula (I) or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exert an inhibitory activity on sodium-dependent nucleoside transporter 2 and are useful for a disease associated with an abnormality of plasma uric acid level. The compounds of the present invention are useful for the prevention or treatment of gout, hyperuricemia, urinary lithiasis, hyperuricemic nephropathy or the like. In the formula, n is 1 or 2; R1 and R2 are H, a halogen atom, cyano group, optionally substituted alkyl group, optionally substituted aryl group or the like; R3 is H, a halogen atom, optionally substituted alkyl group or the like; R9 and R5 are H, a halogen atom, OH or the like; and R6 and RX are H or OH: RY is F or OH.
